Key result
Bolus administration of /kg remifentanil caused severe hemodynamic instability in 4 of 8 patients undergoing coronary artery bypass grafting, prompting early study termination.
Why the study?
Does bolus administration of remifentanil cause severe hemodynamic depression in patients with coronary artery disease undergoing CABG?
Does bolus administration of remifentanil cause severe hemodynamic depression in patients with coronary artery disease undergoing CABG?
Bolus administration of remifentanil causes severe cardiovascular depression in patients with coronary artery disease undergoing CABG and should only be given by slow infusion.
Answers are grounded in this paper and cite their sources.
May warrant caution with bolus remifentanil in CABG; hypothesis-generating and requires prospective trials before practice change.
We compared the hemodynamic effects of a bolus administration of 1 μg/kg remifentanil for 1, 3, and 5 min (1, 0.33, and 0.2 μg · kg−1 · min−1, respectively) in patients scheduled for coronary artery bypass grafting anesthetized with small-dose propofol. The study was terminated after only eight patients had been enrolled (three received remifentanil at a rate of 1.0 μg · kg−1 · min−1, two at 0.33 μg · kg−1 · min−1, and three at 0.2 μg · kg−1 · min−1) because of severe hemodynamic instability, which was particularly marked in four patients and consisted of severe bradycardia in one patient and severe hypotension with a reduction in systemic vascular resistance in three others. One patient showed evidence of myocardial ischemia. All patients responded to therapeutic interventions. The results show that remifentanil should be given only by slow infusion to such patients. Implications This study investigates the effect on the heart and blood vessels of various rates of administration of boluses of a relatively new potent opiate, remifentanil, to patients with coronary artery disease. The results show that remifentanil should be given only by slow infusion to such patients.
No takes yet. Share an insight, caveat, or question.
Elliott et al. (2000) studied Coronary artery disease (n=8). Remifentanil vs. Different infusion rates was evaluated on Hemodynamic effects. Bolus administration of /kg remifentanil caused severe hemodynamic instability in 4 of 8 patients undergoing coronary artery bypass grafting, prompting early study termination.
Synapse has enriched 10 related papers. Consider them for comparative context: